Johnson & Johnson
USUSDJohnson & Johnson (XETRA:JNJ) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 3. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la Empresa
- Sitio Web
- jnj.com
- Relaciones con los Inversores
- investor.jnj.com/overview/default.aspx
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede Central
- New Brunswick, United States
- Consejero Delegado
- Joaquin Duato
- Empleados
- 136 400
- Fundada
- 1886
- Acciones en Circulación
- Capital Flotante
- 2.41 mil M
- Capitalización Bursátil
- 655.37 mil M USD
- Insiders
- 0.05%
- Inversores Institucionales
- 76.73%
- Industria (SIC)
- Pharmaceutical Preparations
- Forma Jurídica
- XSNP
- ISIN
- US4781601046
- LEI
- 549300G0CFPGEF6X2043
- P/E
- 31.7
- Ratio de Reparto
- 60.0%
- FCF
- 22.2 mil M USD
- Pagos / FCF
- 57%
- Deuda
- 49.0 mil M USD1.3 a. de FCF
- Racha de Dividendos
- 56+ a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 28.06.2026 (el último informe de la compañía).
- NAV
Descripción
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Dividendos
Johnson & Johnson (JNJ) paga dividendos trimestralmente. Por año (12 meses hasta e incluyendo el último pago anunciado): 5.32 USD por acción (pagos: 4). Eso representa aproximadamente el 2.08% del precio actual de la acción. La próxima fecha ex-dividendo es el 24.11.2026: 1.34 USD por acción, con pago el 08.12.2026. Historial de dividendos ininterrumpido: 56 años.
| Fecha Ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-11-24 anunciado | 2026-12-08 | 1.3400 USD | 0.5/2.1 % | trimestral | US:JNJ |
| 2026-08-25 | 2026-09-08 | 1.3400 USD | 0.5/1.9 % | trimestral | US:JNJ |
| 2026-05-26 | 2026-06-09 | 1.3400 USD | 0.6/2.2 % | trimestral | US:JNJ |
| 2026-02-24 | 2026-03-10 | 1.3000 USD | 0.5/2.1 % | trimestral | US:JNJ |
| 2025-11-25 | 2025-12-09 | 1.3000 USD | 0.6/2.5 % | trimestral | US:JNJ |
| 2025-08-26 | 2025-09-09 | 1.3000 USD | 0.7/2.8 % | trimestral | US:JNJ |
| 2025-05-27 | 2025-06-10 | 1.3000 USD | 0.9/3.3 % | trimestral | US:JNJ |
| 2025-02-18 | 2025-03-04 | 1.2400 USD | 0.8/3.2 % | trimestral | US:JNJ |
| 2024-11-26 | 2024-12-10 | 1.2400 USD | 0.8/3.2 % | trimestral | US:JNJ |
| 2024-08-27 | 2024-09-10 | 1.2400 USD | 0.5/1.9 % | trimestral | US:JNJ |
| 2024-05-20 | 2024-06-04 | 1.2400 USD | 0.5/1.9 % | trimestral | US:JNJ |
| 2024-02-16 | 2024-03-05 | 1.1900 USD | 0.5/1.9 % | trimestral | US:JNJ |
| 2023-11-20 | 2023-12-05 | 1.1900 USD | 0.5/1.8 % | trimestral | US:JNJ |
| 2023-08-25 | 2023-09-07 | 1.1900 USD | 0.5/1.8 % | trimestral | US:JNJ |
| 2023-05-22 | 2023-06-06 | 1.1900 USD | 0.5/1.8 % | trimestral | US:JNJ |
| 2023-02-17 | 2023-03-07 | 1.1300 USD | 0.4/1.8 % | trimestral | US:JNJ |
| 2022-11-21 | 2022-12-06 | 1.1300 USD | 0.4/1.7 % | trimestral | US:JNJ |
| 2022-08-22 | 2022-09-06 | 1.1300 USD | 0.4/1.7 % | trimestral | US:JNJ |
| 2022-05-23 | 2022-06-07 | 1.1300 USD | 0.4/1.3 % | trimestral | US:JNJ |
| 2022-02-18 | 2022-03-08 | 1.0600 USD | 0.4/0.8 % | trimestral | US:JNJ |
| 2021-11-22 | 2021-12-07 | 1.0600 USD | 0.4/0.4 % | trimestral | US:JNJ |
Principales Accionistas
| Titular | Participación | Acciones | Fecha del Informe |
|---|---|---|---|
| BlackRock | 8.8% | 212.1 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.52% | 157.23 M | 2026-06-30 |
| State Street Corporation | 5.55% | 133.78 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.17% | 76.42 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.67% | 64.37 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 62.38 M | 2026-06-30 |
| Geode Capital Management… | 2.45% | 59.09 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.42% | 58.3 M | 2026-06-30 |
| Morgan Stanley | 1.86% | 44.81 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.35% | 32.48 M | 2026-07-31 |
| NORGES BANK | 1.32% | 31.83 M | 2026-06-30 |
| State Farm Mutual Automo… | 1.31% | 31.59 M | 2026-06-30 |
| Fidelity Concord Street… | 1.29% | 31.13 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 29.45 M | 2026-08-31 |
| Northern Trust Corporati… | 1.19% | 28.79 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 22.91 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.3 M | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.56% | 13.53 M | 2026-04-30 |
| VANGUARD INSTITUTIONAL I… | 0.54% | 13.07 M | 2026-06-30 |
| VANGUARD WHITEHALL FUNDS… | 0.39% | 9.48 M | 2026-04-30 |
| DUATO JOAQUIN BOIX (Chie… | ≈0.01% | 307 837 | 2026-08-13 |
| TAUBERT JENNIFER L (Offi… | ≈0.01% | 194 451 | 2026-08-17 |
| WENGEL KATHRYN E (Chief… | ≈0% | 114 659 | 2026-06-11 |
| WOLK JOSEPH J (Chief Fin… | ≈0% | 85 008 | 2026-02-17 |
| SCHMID TIMOTHY (Officer) | ≈0% | 26 251 | 2026-09-02 |
| SWANSON JAMES D (Chief T… | ≈0% | 25 698 | 2026-02-17 |
| REED JOHN C (Officer) | ≈0% | 24 911 | 2026-05-01 |
| DECKER ROBERT J (Officer… | ≈0% | 24 462 | 2026-02-27 |
| BROADHURST VANESSA (Offi… | ≈0% | 23 003 | 2026-07-20 |
| MULHOLLAND KRISTEN (Offi… | ≈0% | 19 830 | 2026-02-13 |
| The Vanguard Group | — | — | — |
